Viewing Study NCT06104566


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2026-01-04 @ 5:06 PM
Study NCT ID: NCT06104566
Status: RECRUITING
Last Update Posted: 2025-09-18
First Post: 2023-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Global Trial in APG2575 for Patients With CLL/SLL
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module